This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2018, 14, 484–498, doi:10.3762/bjoc.14.34
Graphical Abstract
Figure 1: a) Ribbon and b) surface depictions of the cholera toxin: A11 domain in light blue; A12 domain in d...
Figure 2: a) Structure of the cholera toxin showing the location of its carbohydrate binding sites and the st...
Figure 3: Bernardi and co-workers’ designed oligosaccharide mimetics of GM1.
Figure 4: Structure of monomeric ligands. X = amino acid residues, aminoalkyl, 1,2,3 triazoles; n = 1, 2; R =...
Figure 5: Bivalent inhibitor designed and synthesised by Pickens et al.
Figure 6: Bivalent inhibitor designed and synthesized by Arosio et al.
Figure 7: Bivalent inhibitors designed and synthesised by Leaver and Liu.
Figure 8: Bivalent and tetravalent inhibitor designed and synthesised by Pieters, and Bernardi et al.
Figure 9: Cyclic inhibitors synthesised by Kumar et al. for CT.
Figure 10: The star-shaped inhibitors reported by Fan, Hol and co-workers.
Figure 11: Differently sized cyclic decavalent peptide core designed by Zhang et al.
Figure 12: Calix[5]arene core-based pentavalent inhibitor designed by Garcia-Hartjes et al.
Figure 13: Corannulene core-based pentavalent inhibitor designed by Mattarella et al.
Figure 14: Pentavalent inhibitor designed by Pieters and co-workers.
Figure 15: Neoglycoprotein inhibitor based on a non-binding mutant of CTB.
Figure 16: Octavalent inhibitor designed by Pieters, Bernardi and co-workers.
Figure 17: Hetero-bifunctional inhibitor designed by Bundle and co-workers.
Figure 18: Glycopolymers with exchangeable sugar ligands and variable length linkers.
Beilstein J. Org. Chem. 2010, 6, No. 19, doi:10.3762/bjoc.6.19
Scheme 1: a) Boons’ chiral auxiliary-based approach to α-stereoselective glycosylations. b) Modified strategy...
Scheme 2: Benzyne generation from 1-ABT.
Scheme 3: Oxathiane donor synthesis.
Scheme 4: Arylation/acetate glycosylation of oxathiane glycosyl donors.